Article
Corticosterone, brain mineralocorticoid receptors (MRS) and the activity of the hypothalamic-pituitary-adrenal (hpa) axis: The Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis

https://doi.org/10.1016/0306-4530(95)00003-7Get rights and content

Abstract

In this study we report a series of differences in brain and peripheral elements regulating the hypothalamic-pituitary-adrenal (HPA) axis between male LEW and Wistar rats. We found: (i) differential properties of mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) in the brain (hippocampus, hypothalamus) and pituitary: LEW rats displayed an increased capacity of MRs in the hippocampus and hypothalamus and a decreased capacity of glucocorticoid receptors GRs in the pituitary. The binding affinity (Kd) for MRs and GRs in the hippocampus was comparable. (ii) Lower concentrations of corticotropin releasing hormone (CRH) mRNA were detected in the nucleus paraventicularis of the hypothalamus of LEW rats. (iii) Adrenal weight was similar in LEW and Wistar rats; however, LEW rats had about 30% less adrenocortical cells. Subjecting adrenocortical cells to increasing doses of ACTH1−24 in vitro resulted in about a 60% smaller release of corticosterone in LEW rats. (iv) LEW rats escaped dexamethasone suppression showing increased basal levels of endogenous ACTH, but responded with a comparable release of corticosterone to the IV injection of 5 ng ACTH1−24. (v) LEW rats responded to a variety of stimuli: adrenalectomy under ether anaesthesia, a novel environment, a tail nick and restraint or an immunological challenge, with lower circulating ACTH and corticosterone plasma levels than Wistar rats. (vi) Evening levels of ACTH and corticosterone were lower in LEW than Wistar rats but did not differ in the morning. Blockade of brain MRs in the evening by a central injection of the specific MR antagonist RU28318 in LEW rats resulted in increased circulating levels of ACTH and corticosterone. (vii) Levels of corticosterond-binding proteins were lower in one-day adrenalectomized LEW rats, indicating higher levels of free corticosterone. (viii) LEW rats had a smaller thymus than Wistar rats. Taken together, the receptor binding data correspond to a decreased neuroendocrine responsiveness of LEW rats to stress. We suggest that the shift in the central MR/GR balance of LEW rats, i.e. augmented MR-mediated effects of corticosterone, is the central regulating mechanism of the hyporeactive HPA axis in this rat strain. Lower levels of CRH mRNA in the hypothalamus and lower levels of ACTH and corticosterone in response to various stimuli, as well as the hyporesponsive adrenals to exogenous ACTH, are apparently the consequences of the life-long suppressive action of corticosterone via central MRs.

References (51)

  • C.G. Smith et al.

    Increased hypothalamic (3H)flunitrazepam binding in hypothalamic-pituitaryadrenal axis hyporesponsive Lewis rats

    Brain Res

    (1992)
  • E.M. Sternberg et al.

    Corticotropin releasing hormone related behavioral and neuroendocrine responses to stress in Lewis and Fischer rats

    Brain Res

    (1992)
  • S.F. Akana et al.

    Corticosterone: narrow range required for normal body and thymus weight and ACTH

    Am J Physiol

    (1985)
  • Ph.L. Altman et al.

    Inbred and Genetically Defined Strains of Laboratory Animals. Part 1: Mouse and Rat

  • M.J. Bradbury et al.

    Roles of Type I and II corticosteroid receptors in regulation of basal activity in the hypothalamo-pituitary-adrenal axis during the diurnal trough and the peak: evidence for a nonadditive effect of combined receptor occupation

    Endocrinology

    (1994)
  • J.H. Brakkee et al.

    A simple technique for rapid implantation of a permanent cannula into the rat brain ventricular system

    Lab Anim Sci

    (1979)
  • A.E. Calogero et al.

    Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone

    Neuroendocrinology

    (1992)
  • M.F. Dallman et al.

    Pharmacological evidence that the inhibition of diurnal adrenocorticotropin secretion by corticosteroids is mediated via type I corticosterone-preferring receptors

    Endocrinology

    (1989)
  • H.H.van Dijken et al.

    Short inescapable stress produces long-lasting changes in the brain-pituitary-adrenal axis of adult male rats

    Neuroendocrinology

    (1993)
  • B.J. Gertz et al.

    Chronic administration of corticotropin-releasing factor increases pituitary corticotroph number

    Endocrinology

    (1987)
  • H.J.M. Goverde et al.

    Improved sensitivity to adrenocorticotrophin after purification and pre-incubation of isolated rat adrenal cells

    Acta Endocrinol

    (1980)
  • M.S. Harbuz et al.

    HPA axis responses to acute stress and adrenalectomy during adjuvant-induced arthritis in the rat

    Am J Physiol

    (1993)
  • D.L. Healy et al.

    The thymus adrenal connection: thymosin has corticotropin releasing activity in primates

    Science

    (1983)
  • J.P. Herman et al.

    Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis

    J Neurosci

    (1989)
  • S.B. Hu et al.

    Dexamethasone and aldosterone modulate corticotropinreleasing factor-41 release from cultured rat fetal hypothalamic cells through type II and type I corticosteroid receptors respectively

    Neuroendocrinology

    (1992)
  • Cited by (0)

    View full text